Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dyserythropoietic anemia].

W Fereberger

    Acta Medica Austriaca. Supplement
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Dyserythropoiesis involves ineffective red blood cell production with unknown molecular causes. Acquired forms are common, increasing risks for transfusion siderosis, premalignant conditions, and tumors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Pathologic enzyme patterns in sonographically verified liver metastases].

    Wiener medizinische Wochenschrift (1946)·1987
    Same author

    Combination chemotherapy with aclarubicin in metastatic breast cancer.

    European journal of haematology. Supplementum·1987
    Same author

    [Pneumatic cold cap for the prevention of doxorubicin-induced alopecia].

    Wiener medizinische Wochenschrift (1946)·1984
    Same author

    [Emergencies in oncology].

    Wiener medizinische Wochenschrift (1946)·1984
    Same author

    [Acute disorders of hemostasis].

    Wiener medizinische Wochenschrift (1946)·1984
    Same author

    [Iron and iron binding proteins in inflammations and tumors].

    Wiener medizinische Wochenschrift (1946)·1984
    Same journal

    2004 Annual Spring Meeting of the Austrian Society of Hematology and Oncology. 15-17 April 2004, Vienna, Austria. Abstracts.

    Acta medica Austriaca. Supplement·2004
    Same journal

    [Abstracts of the 31st Annual Meeting of the Austrian Society of Diabetes. 27-29 November 2003].

    Acta medica Austriaca. Supplement·2004
    Same journal

    Abstracts of the Annual Spring Meeting of the Austrian Society of Hematology and Oncology. Dornbirn, 27-29 March 2003.

    Acta medica Austriaca. Supplement·2003
    Same journal

    [30th Annual Meeting of the Austrian Society of Diabetes. 28-30 November 2002, Graz. Abstracts].

    Acta medica Austriaca. Supplement·2003
    Same journal

    Abstracts of the 4th Middle European Congress of Internal Medicine. July 1-3, 1999.

    Acta medica Austriaca. Supplement·2003
    Same journal

    1999 Spring Meeting of the Austrian Society of Hematology and Oncology. Abstracts.

    Acta medica Austriaca. Supplement·2003
    See all related articles

    Area of Science:

    • Hematology
    • Molecular Biology
    • Pathophysiology

    Context:

    • Dyserythropoiesis presents with increased ineffective erythropoiesis.
    • Molecular mechanisms underlying dyserythropoiesis remain largely unknown.
    • Similarities exist in structural and biochemical characteristics across various etiologies.

    Purpose:

    • To elucidate the molecular underpinnings of dyserythropoiesis.
    • To differentiate between congenital and acquired forms.
    • To identify therapeutic targets and associated risks.

    Summary:

    • The primary symptom of dyserythropoiesis is heightened, ineffective erythropoiesis with distinct morphological and functional traits.
    • Both rare congenital and frequent acquired forms of dyserythropoiesis are observed.

    Related Experiment Videos

  • Causal therapies are limited to deficiency and toxic states, with other patients facing risks of transfusion hypersiderosis.

    • Impact:

    • Understanding the molecular basis can lead to targeted therapies.
    • Early identification of acquired forms may mitigate risks of premalignant diseases and tumors.
    • Improved management strategies for transfusion hypersiderosis in dyserythropoiesis patients.